SCHEMBL28649262

SCHEMBL28649262

O=Cc1ccc(C(=O)NCc2ccccc2Cl)cc1

nearest known ligand 0.69

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.69
L3MBTL1 Q9Y468 1/20 0.57
KMT2A Q03164 2/20 0.57
MEN1 O00255 1/20 0.57
NPC1 O15118 1/20 0.57
RAB9A P51151 1/20 0.57
LMNA P02545 2/20 0.56
MAPT P10636 1/20 0.56
TP53 P04637 1/20 0.53
KDM4E B2RXH2 1/20 0.53
HIF1A Q16665 1/20 0.52
POLB P06746 1/20 0.52
ALDH1A1 P00352 2/20 0.52
CASP6 P55212 1/20 0.52
EPHX2 P34913 2/20 0.52
NR1H4 Q96RI1 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2912570 0.84 SMN1; SMN2 (0.82) SMN1; SMN2L3MBTL1KMT2AMEN1NPC1
SCHEMBL20269915 0.83 LMNA (0.67) SMN1; SMN2KMT2AMEN1LMNAMAPT
SCHEMBL28648931 0.82 KMT2A (0.65) SMN1; SMN2KMT2AMAPTALDH1A1EPHX2
SCHEMBL28646195 0.82 HPGD (0.72) KMT2ALMNAMAPTTP53KDM4E
SCHEMBL3590191 0.82 SMN1; SMN2 (0.73) SMN1; SMN2L3MBTL1KMT2AMEN1NPC1
SCHEMBL14531874 0.82 SMN1; SMN2 (0.73) SMN1; SMN2L3MBTL1KMT2AMEN1NPC1
SCHEMBL95008 0.82 SMN1; SMN2 (0.73) SMN1; SMN2L3MBTL1KMT2AMEN1NPC1
SCHEMBL13947384 0.82 SMN1; SMN2 (0.73) SMN1; SMN2L3MBTL1KMT2AMEN1NPC1
SCHEMBL3034646 0.79 SMN1; SMN2 (0.83) SMN1; SMN2L3MBTL1KMT2AMEN1NPC1
SCHEMBL28648368 0.79 EPHX2 (0.68) EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108026028-B Treatment of diabetes and metabolic syndrome with novel dual modulators of soluble epoxide hydrolase and peroxisome proliferator-activated receptors 威斯康星州医药大学股份有限公司 2021-11-09 CN disclosed